Literature DB >> 25123110

Functional outcome in people at high risk for psychosis predicted by thalamic glutamate levels and prefronto-striatal activation.

Paul Allen1, Christopher A Chaddock1, Alice Egerton1, Oliver D Howes1, Gareth Barker2, Ilaria Bonoldi3, Paolo Fusar-Poli1, Robin Murray1, Philip McGuire1.   

Abstract

Little is known about the neurobiological factors that determine functional outcome in people at high risk for psychosis. We use multimodal neuroimaging to investigate whether cortical responses during a cognitive task and thalamic glutamate levels were associated with subsequent functional outcome. Sixty subjects participated: 27 healthy controls (CTRL) and 33 at ultrahigh risk (UHR) for psychosis. At baseline, cortical responses during a verbal fluency task were measured using functional Magnetic Resonance Imaging (fMRI) and proton Magnetic Resonance Spectroscopy (1H-MRS) was used to measure thalamic glutamate levels. The UHR subjects were then followed clinically for a mean duration of 18 months, and subdivided into "good" and "poor" functional outcome subgroups according to their Global Assessment of Function score at follow-up. UHR subjects with a poor functional outcome showed greater cortical and subcortical activation than UHR subjects with a good functional outcome. They also had lower levels of thalamic glutamate and showed a negative relationship between thalamic glutamate levels and prefrontal-striatal activation that was not present in the good functional outcome or control groups. In people at high risk for psychosis, their subsequent level of functioning may depend on the extent to which neurophysiological and neurochemical function is perturbed when they first present to clinical services.
© The Author 2014. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  functional MRI; functional outcomes; glutamate; psychosis; spectroscopy; ultra-high risk

Mesh:

Substances:

Year:  2014        PMID: 25123110      PMCID: PMC4332951          DOI: 10.1093/schbul/sbu115

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  47 in total

1.  Impact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis.

Authors:  Ricardo E Carrión; Terry E Goldberg; Danielle McLaughlin; Andrea M Auther; Christoph U Correll; Barbara A Cornblatt
Journal:  Am J Psychiatry       Date:  2011-05-02       Impact factor: 18.112

2.  Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis.

Authors:  P Fusar-Poli; J M Stone; M R Broome; I Valli; A Mechelli; M A McLean; D J Lythgoe; R L O'Gorman; G J Barker; P K McGuire
Journal:  Arch Gen Psychiatry       Date:  2011-05-02

3.  Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing.

Authors:  Rajendra A Morey; Seniha Inan; Teresa V Mitchell; Diana O Perkins; Jeffrey A Lieberman; Aysenil Belger
Journal:  Arch Gen Psychiatry       Date:  2005-03

4.  'At-risk' for psychosis research: where are we heading?

Authors:  A Lin; B Nelson; A R Yung
Journal:  Epidemiol Psychiatr Sci       Date:  2012-07-30       Impact factor: 6.892

5.  Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis.

Authors:  P Fusar-Poli; O D Howes; P Allen; M Broome; I Valli; M-C Asselin; A J Montgomery; P M Grasby; P McGuire
Journal:  Mol Psychiatry       Date:  2009-12-01       Impact factor: 15.992

6.  Language network dysfunction as a predictor of outcome in youth at clinical high risk for psychosis.

Authors:  Fred W Sabb; Theo G M van Erp; Molly E Hardt; Mirella Dapretto; Rochelle Caplan; Tyrone D Cannon; Carrie E Bearden
Journal:  Schizophr Res       Date:  2009-10-27       Impact factor: 4.939

7.  Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study.

Authors:  Oliver D Howes; Subrata K Bose; Federico Turkheimer; Isabel Valli; Alice Egerton; Lucia R Valmaggia; Robin M Murray; Philip McGuire
Journal:  Am J Psychiatry       Date:  2011-07-18       Impact factor: 18.112

Review 8.  Early interventions to prevent psychosis: systematic review and meta-analysis.

Authors:  Megan R Stafford; Hannah Jackson; Evan Mayo-Wilson; Anthony P Morrison; Tim Kendall
Journal:  BMJ       Date:  2013-01-18

9.  Parallel driving and modulatory pathways link the prefrontal cortex and thalamus.

Authors:  Basilis Zikopoulos; Helen Barbas
Journal:  PLoS One       Date:  2007-09-05       Impact factor: 3.240

10.  Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis.

Authors:  Alice Egerton; James M Stone; Christopher A Chaddock; Gareth J Barker; Ilaria Bonoldi; Rachel M Howard; Kate Merritt; Paul Allen; Oliver D Howes; Robin M Murray; Mary A McLean; David J Lythgoe; Ruth L O'Gorman; Philip K McGuire
Journal:  Neuropsychopharmacology       Date:  2014-06-11       Impact factor: 7.853

View more
  23 in total

1.  Reduced Thickness of the Anterior Cingulate Cortex in Individuals With an At-Risk Mental State Who Later Develop Psychosis.

Authors:  Yoichiro Takayanagi; Sue Kulason; Daiki Sasabayashi; Tsutomu Takahashi; Naoyuki Katagiri; Atsushi Sakuma; Chika Obara; Mihoko Nakamura; Mikio Kido; Atsushi Furuichi; Yumiko Nishikawa; Kyo Noguchi; Kazunori Matsumoto; Masafumi Mizuno; J Tilak Ratnanather; Michio Suzuki
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

Review 2.  A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk.

Authors:  Valerie J Sydnor; David R Roalf
Journal:  Schizophr Res       Date:  2020-07-25       Impact factor: 4.939

Review 3.  Translating the MAM model of psychosis to humans.

Authors:  Gemma Modinos; Paul Allen; Anthony A Grace; Philip McGuire
Journal:  Trends Neurosci       Date:  2014-12-30       Impact factor: 13.837

4.  Increased Striatal and Reduced Prefrontal Cerebral Blood Flow in Clinical High Risk for Psychosis.

Authors:  Jochen Kindler; Frauke Schultze-Lutter; Martinus Hauf; Thomas Dierks; Andrea Federspiel; Sebastian Walther; Benno G Schimmelmann; Daniela Hubl
Journal:  Schizophr Bull       Date:  2018-01-13       Impact factor: 9.306

5.  Volume Reduction of the Dorsal Lateral Prefrontal Cortex Prior to the Onset of Frank Psychosis in Individuals with an At-Risk Mental State.

Authors:  Yoichiro Takayanagi; Sue Kulason; Daiki Sasabayashi; Tsutomu Takahashi; Naoyuki Katagiri; Atsushi Sakuma; Noriyuki Ohmuro; Masahiro Katsura; Shimako Nishiyama; Mikio Kido; Atsushi Furuichi; Kyo Noguchi; Kazunori Matsumoto; Masafumi Mizuno; J Tilak Ratnanather; Michio Suzuki
Journal:  Cereb Cortex       Date:  2022-05-14       Impact factor: 4.861

6.  Neuroanatomical Predictors of Functional Outcome in Individuals at Ultra-High Risk for Psychosis.

Authors:  Renate L E P Reniers; Ashleigh Lin; Alison R Yung; Nikolaos Koutsouleris; Barnaby Nelson; Vanessa L Cropley; Dennis Velakoulis; Patrick D McGorry; Christos Pantelis; Stephen J Wood
Journal:  Schizophr Bull       Date:  2017-03-01       Impact factor: 9.306

7.  Association of Hippocampal Glutamate Levels With Adverse Outcomes in Individuals at Clinical High Risk for Psychosis.

Authors:  Matthijs G Bossong; Mathilde Antoniades; Matilda Azis; Carly Samson; Beverley Quinn; Ilaria Bonoldi; Gemma Modinos; Jesus Perez; Oliver D Howes; James M Stone; Paul Allen; Philip McGuire
Journal:  JAMA Psychiatry       Date:  2019-02-01       Impact factor: 21.596

Review 8.  Revisiting the Basic Symptom Concept: Toward Translating Risk Symptoms for Psychosis into Neurobiological Targets.

Authors:  Frauke Schultze-Lutter; Martin Debbané; Anastasia Theodoridou; Stephen J Wood; Andrea Raballo; Chantal Michel; Stefanie J Schmidt; Jochen Kindler; Stephan Ruhrmann; Peter J Uhlhaas
Journal:  Front Psychiatry       Date:  2016-01-28       Impact factor: 4.157

9.  Corticolimbic dysfunction during facial and prosodic emotional recognition in first-episode psychosis patients and individuals at ultra-high risk.

Authors:  Huai-Hsuan Tseng; Jonathan P Roiser; Gemma Modinos; Irina Falkenberg; Carly Samson; Philip McGuire; Paul Allen
Journal:  Neuroimage Clin       Date:  2016-09-08       Impact factor: 4.881

10.  Brain development in adolescents at ultra-high risk for psychosis: Longitudinal changes related to resilience.

Authors:  Sanne de Wit; Lara M Wierenga; Bob Oranje; Tim B Ziermans; Patricia F Schothorst; Herman van Engeland; René S Kahn; Sarah Durston
Journal:  Neuroimage Clin       Date:  2016-08-13       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.